WHO ICTRP trial
Rivaroxaban for treatment in venous thrombosis in young children
EUCTR2014-000566-22-IE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2014-000566-22-IE |
|---|---|
| Public title | Rivaroxaban for treatment in venous thrombosis in young children |
| Scientific title | 30-day, single-arm study of the safety, efficacy and the pharmacokinetic and pharmacodynamic properties of oral rivaroxaban in young children with various manifestations of venous thrombosis - EINSTEIN Junior Phase II-part B: oral rivaroxaban in young children with venous |
| Primary sponsor | Bayer HealthCare AG |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | United States;Hong Kong;Finland;Spain;Ireland;Austria;Russian Federation;Israel;Italy;Switzerland;United… |
| Conditions | Venous Thrombosis MedDRA version: 18.0 Level: LLT Classification code 10066899 Term: Venous thromboembolism System Organ Class: 100000004866 ;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14] |
| Interventions | Product Name: Xarelto Product Code: BAY59-7939 Pharmaceutical Form: Oral suspension INN or Proposed INN: RIVAROXABAN CAS Number: 366789-02-8 Current Sponsor code: BAY 59-7939 Concentration unit: mg/ml milligram(s)/millilitre Concentration… |
| Registration date | May 15, 2014 |
| Target size | 20 |
| Secondary IDs | BAY59-7939/14374 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: